Literature DB >> 28198105

Antibiotic-dependent perturbations of extended spectrum beta-lactamase producing Klebsiella pneumoniae proteome.

Moo-Jin Suh1, Sarah L Keasey1,2, Ernst E Brueggemann1, Robert G Ulrich1.   

Abstract

Extended spectrum beta-lactamase producing Klebsiella pneumoniae (ESBL-KP) causes life-threatening infections in susceptible and immuno-compromised individuals. Because of the emergence of multidrug resistance and tolerance, it is crucial to better understand the mechanisms by which ESBL-KP can adapt to antibiotic stress. The aim of this study was to provide an overview of the global proteome changes occurring in ESBL-KP in response to sub-lethal concentrations of the antibiotics doxycycline (DC, bacteriostatic) and streptomycin (SM, bactericidal), which both impair ribosomal synthesis of bacterial proteins. These results represent the greatest experimental coverage of the ESBL-KP proteome yet described. The 1538 proteins, representing 30% of the 5126 predicted KP gene products were identified from the combined experimental groups. Antibiotic stress resulted in significantly elevated levels of 42 proteins for DC and 55 for SM treatments, whereas 53 proteins were reduced for DC- and six for SM-treated bacteria. Specifically, the ESBL-KP response to DC was accompanied by the reduced levels of the porins LamB, CirA, FepA, and OmpC. In contrast to DC, the stress response to SM demonstrated a dramatic increase in the peroxidase detoxification pathway proteins PutA, KatG, KatE, and Dps, which prevent harmful hydroxyl radical formation. The results from this proteomic study are important for understanding adaptive responses to antibiotics, and may provide novel targets for the development of new therapeutic strategies.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Doxycycline; Klebsiella pneumoniae; Label-free quantitative proteomics; Streptomycin

Mesh:

Substances:

Year:  2017        PMID: 28198105     DOI: 10.1002/pmic.201700003

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  5 in total

1.  The Integration of Proteomics and Metabolomics Data Paving the Way for a Better Understanding of the Mechanisms Underlying Microbial Acquired Drug Resistance.

Authors:  Suereta Fortuin; Nelson C Soares
Journal:  Front Med (Lausanne)       Date:  2022-05-06

2.  The use of SWATH to analyse the dynamic changes of bacterial proteome of carbapanemase-producing Escherichia coli under antibiotic pressure.

Authors:  Hanna E Sidjabat; Jolene Gien; David Kvaskoff; Keith Ashman; Kanchan Vaswani; Sarah Reed; Ross P McGeary; David L Paterson; Amanda Bordin; Gerhard Schenk
Journal:  Sci Rep       Date:  2018-03-01       Impact factor: 4.379

3.  Decreased Antibiotic Susceptibility Driven by Global Remodeling of the Klebsiella pneumoniae Proteome.

Authors:  Sarah L Keasey; Moo-Jin Suh; Sudipto Das; Candace D Blancett; Xiankun Zeng; Thorkell Andresson; Mei G Sun; Robert G Ulrich
Journal:  Mol Cell Proteomics       Date:  2019-01-07       Impact factor: 5.911

4.  Proteomic Signatures of Antimicrobial Resistance in Yersinia pestis and Francisella tularensis.

Authors:  Brooke L Deatherage Kaiser; Dawn N Birdsell; Janine R Hutchison; Johanna Thelaus; Sarah C Jenson; Voahangy Andrianaivoarimanana; Mona Byström; Kerstin Myrtennäs; Ryelan F McDonough; Roxanne D Nottingham; Jason W Sahl; Herbert P Schweizer; Minoarisoa Rajerison; Mats Forsman; David S Wunschel; David M Wagner
Journal:  Front Med (Lausanne)       Date:  2022-02-10

5.  Identification of Antibiotic Resistance Proteins via MiCId's Augmented Workflow. A Mass Spectrometry-Based Proteomics Approach.

Authors:  Gelio Alves; Aleksey Ogurtsov; Roger Karlsson; Daniel Jaén-Luchoro; Beatriz Piñeiro-Iglesias; Francisco Salvà-Serra; Björn Andersson; Edward R B Moore; Yi-Kuo Yu
Journal:  J Am Soc Mass Spectrom       Date:  2022-05-02       Impact factor: 3.262

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.